サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1292517

筋弛緩薬の世界市場規模、シェア、産業動向分析レポート薬剤タイプ別、投与経路別（経口・注射）、流通チャネル別、地域別展望・予測、2023年～2029年

Global Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029
出版日: | 発行: KBV Research | ページ情報: 英文 194 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
筋弛緩薬の世界市場規模、シェア、産業動向分析レポート薬剤タイプ別、投与経路別（経口・注射）、流通チャネル別、地域別展望・予測、2023年～2029年
出版日: 2023年05月31日
発行: KBV Research
ページ情報: 英文 194 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

筋弛緩薬市場規模は、2029年には47億米ドルに達し、予測期間中にCAGR4.3%の市場成長率で上昇すると予測されています。

しかし、肝疾患や発作などの既往症や問題がある患者は、副作用のリスクが高まります。また、妊娠を計画している妊婦や授乳中の女性は特に注意が必要です。全身弛緩薬である筋弛緩薬は、通常、眠気やぐずりを誘発します。そのため、筋弛緩剤の影響下にある状態で、自動車の運転や重要な意思決定を行うことは安全ではありません。

薬物タイプの展望

薬剤の種類により、市場は骨格系、顔面筋弛緩剤、神経筋遮断剤に区分されます。骨格系セグメントは、2022年に最大の収益シェアを獲得して市場を独占しました。これは、骨格筋弛緩剤が当初、筋肉の痙攣や腰痛を一時的に治療するために承認されたからです。現在では、慢性的な痛みだけでなく、他のさまざまな症状の治療にも一般的に使用されています。また、人が医療機関を受診する理由はさまざまですが、最も多いのは痛みです。そのため、慢性的な痛みや筋肉の痙攣の治療に使用されることで、このセグメントの成長を促進することが期待されます。

投与経路の展望

投与経路により、市場は経口剤と注射剤に分けられます。注射剤セグメントは、2022年の市場においてかなりの収益シェアを獲得しました。これは、市場の最重要企業が革新的な新アイテムの創出に取り組んでいることに起因しています。全身麻酔を受ける前に、この筋弛緩剤は患者に投与されます。また、アンチエイジング薬における筋弛緩剤注射の最もよく知られた用途の1つは、額やまぶたのしわやほうれい線を目立たなくすることであり、このセグメントの成長を助けています。

流通チャネル別の展望

流通チャネル別では、病院薬局、小売薬局、オンライン薬局に分類されます。病院薬局セグメントは、2022年の市場で最大の収益シェアを示しました。これは、認知度の拡大、臨床や病院への訪問の増加によるものです。また、老年人口の増加は、このセグメントの拡大を推進する重要な要因となっています。これは、高齢者がさまざまな慢性疾患のために入院し、その際に薬剤を投与されることが多いためです。このように、病院への入院や老年人口の増加により、この分野は拡大すると予想されます。

地域別展望

地域別では、北米、欧州、アジア太平洋、LAMEAで分析しています。北米地域は、2022年の市場において最も高い収益シェアを記録しました。この成長は、政府投資の増加、慢性疾患の発生率の上昇、同地域の高品質なインフラに起因しています。外科手術の増加や可処分所得の高さから、市場の拡大が期待されています。また、この地域には高齢者人口が多いため、慢性腰痛の有病率が高く、同地域の市場成長をさらに加速させる要因となっています。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第3章 世界の筋弛緩薬市場：薬剤の種類別

  • 世界の骨格市場：地域別
  • 世界の神経筋遮断薬市場：地域別
  • 世界の顔面筋弛緩薬市場：地域別

第4章 世界の筋弛緩薬市場：投与経路別

  • 世界の口腔市場：地域別
  • 世界の注射剤市場：地域別

第5章 世界の筋弛緩薬市場：流通チャネル別

  • 世界の病院薬局市場：地域別
  • 世界の小売薬局市場：地域別
  • 世界のオンライン薬局市場：地域別

第6章 世界の筋弛緩薬市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第7章 企業プロファイル

  • Amneal Pharmaceuticals, Inc
  • Ipsen Pharma Biotech SAS
  • Merz Pharma GmbH & Co KGaA
  • Mallinckrodt PLC
  • Teva Pharmaceutical Industries Ltd
  • Eisai Co, Ltd.
  • Endo International PLC
  • Vertical Pharmaceuticals, LLC
  • SteriMax Inc
  • Metacel Pharmaceuticals, LLC
図表

LIST OF TABLES

  • TABLE 1 Global Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 2 Global Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 3 Global Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 4 Global Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 5 Global Skeletal Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Skeletal Market by Region, 2023 - 2029, USD Million
  • TABLE 7 Global Neuromuscular Blocking Agents Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Neuromuscular Blocking Agents Market by Region, 2023 - 2029, USD Million
  • TABLE 9 Global Facial Muscle Relaxant Drugs Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Facial Muscle Relaxant Drugs Market by Region, 2023 - 2029, USD Million
  • TABLE 11 Global Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 12 Global Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 13 Global Oral Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Oral Market by Region, 2023 - 2029, USD Million
  • TABLE 15 Global Injectable Market by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Injectable Market by Region, 2023 - 2029, USD Million
  • TABLE 17 Global Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 18 Global Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 19 Global Hospital Pharmacy Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Hospital Pharmacy Market by Region, 2023 - 2029, USD Million
  • TABLE 21 Global Retail Pharmacy Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Retail Pharmacy Market by Region, 2023 - 2029, USD Million
  • TABLE 23 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 25 Global Muscle Relaxant Drugs Market by Region, 2019 - 2022, USD Million
  • TABLE 26 Global Muscle Relaxant Drugs Market by Region, 2023 - 2029, USD Million
  • TABLE 27 North America Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 28 North America Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 29 North America Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 30 North America Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 31 North America Skeletal Market by Country, 2019 - 2022, USD Million
  • TABLE 32 North America Skeletal Market by Country, 2023 - 2029, USD Million
  • TABLE 33 North America Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
  • TABLE 34 North America Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
  • TABLE 35 North America Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 36 North America Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 37 North America Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 38 North America Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 39 North America Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 41 North America Injectable Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Injectable Market by Country, 2023 - 2029, USD Million
  • TABLE 43 North America Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 44 North America Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 45 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 47 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Retail Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 49 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 50 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 51 North America Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 53 US Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 54 US Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 55 US Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 56 US Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 57 US Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 58 US Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 59 US Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 60 US Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 61 Canada Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 62 Canada Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 63 Canada Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 64 Canada Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 65 Canada Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 66 Canada Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 67 Canada Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 68 Canada Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 69 Mexico Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 70 Mexico Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 71 Mexico Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 72 Mexico Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 73 Mexico Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 74 Mexico Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 75 Mexico Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 76 Mexico Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 77 Rest of North America Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 78 Rest of North America Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 79 Rest of North America Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 80 Rest of North America Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 81 Rest of North America Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 82 Rest of North America Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 83 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 84 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 85 Europe Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 86 Europe Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 87 Europe Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 88 Europe Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 89 Europe Skeletal Market by Country, 2019 - 2022, USD Million
  • TABLE 90 Europe Skeletal Market by Country, 2023 - 2029, USD Million
  • TABLE 91 Europe Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
  • TABLE 92 Europe Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
  • TABLE 93 Europe Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 94 Europe Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 95 Europe Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 96 Europe Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 97 Europe Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 98 Europe Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 99 Europe Injectable Market by Country, 2019 - 2022, USD Million
  • TABLE 100 Europe Injectable Market by Country, 2023 - 2029, USD Million
  • TABLE 101 Europe Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 102 Europe Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 103 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 104 Europe Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 105 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Retail Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 107 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 109 Europe Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 111 Germany Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 112 Germany Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 113 Germany Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 114 Germany Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 115 Germany Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 116 Germany Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 117 Germany Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 118 Germany Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 119 UK Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 120 UK Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 121 UK Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 122 UK Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 123 UK Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 124 UK Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 125 UK Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 126 UK Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 127 France Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 128 France Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 129 France Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 130 France Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 131 France Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 132 France Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 133 France Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 134 France Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 135 Russia Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 136 Russia Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 137 Russia Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 138 Russia Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 139 Russia Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 140 Russia Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 141 Russia Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 142 Russia Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 143 Spain Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 144 Spain Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 145 Spain Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 146 Spain Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 147 Spain Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 148 Spain Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 149 Spain Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 150 Spain Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 151 Italy Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 152 Italy Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 153 Italy Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 154 Italy Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 155 Italy Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 156 Italy Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 157 Italy Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 158 Italy Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 159 Rest of Europe Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 160 Rest of Europe Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 161 Rest of Europe Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 162 Rest of Europe Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 163 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 164 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 165 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 166 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 167 Asia Pacific Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 168 Asia Pacific Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 169 Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 170 Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 171 Asia Pacific Skeletal Market by Country, 2019 - 2022, USD Million
  • TABLE 172 Asia Pacific Skeletal Market by Country, 2023 - 2029, USD Million
  • TABLE 173 Asia Pacific Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
  • TABLE 174 Asia Pacific Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
  • TABLE 175 Asia Pacific Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 176 Asia Pacific Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 177 Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 178 Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 179 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 180 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 181 Asia Pacific Injectable Market by Country, 2019 - 2022, USD Million
  • TABLE 182 Asia Pacific Injectable Market by Country, 2023 - 2029, USD Million
  • TABLE 183 Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 184 Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 185 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 186 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 187 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 188 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 190 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 191 Asia Pacific Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 193 China Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 194 China Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 195 China Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 196 China Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 197 China Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 198 China Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 199 China Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 200 China Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 201 Japan Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 202 Japan Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 203 Japan Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 204 Japan Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 205 Japan Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 206 Japan Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 207 Japan Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 208 Japan Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 209 India Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 210 India Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 211 India Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 212 India Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 213 India Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 214 India Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 215 India Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 216 India Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 217 South Korea Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 218 South Korea Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 219 South Korea Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 220 South Korea Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 221 South Korea Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 222 South Korea Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 223 South Korea Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 224 South Korea Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 225 Singapore Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 226 Singapore Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 227 Singapore Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 228 Singapore Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 229 Singapore Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 230 Singapore Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 231 Singapore Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 232 Singapore Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 233 Malaysia Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 234 Malaysia Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 235 Malaysia Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 236 Malaysia Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 237 Malaysia Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 238 Malaysia Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 239 Malaysia Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 240 Malaysia Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 241 Rest of Asia Pacific Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 242 Rest of Asia Pacific Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 243 Rest of Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 244 Rest of Asia Pacific Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 245 Rest of Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 246 Rest of Asia Pacific Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 247 Rest of Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 248 Rest of Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 249 LAMEA Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 250 LAMEA Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 251 LAMEA Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 252 LAMEA Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 253 LAMEA Skeletal Market by Country, 2019 - 2022, USD Million
  • TABLE 254 LAMEA Skeletal Market by Country, 2023 - 2029, USD Million
  • TABLE 255 LAMEA Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
  • TABLE 256 LAMEA Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
  • TABLE 257 LAMEA Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 258 LAMEA Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 259 LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 260 LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 261 LAMEA Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 262 LAMEA Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 263 LAMEA Injectable Market by Country, 2019 - 2022, USD Million
  • TABLE 264 LAMEA Injectable Market by Country, 2023 - 2029, USD Million
  • TABLE 265 LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 266 LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 267 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 268 LAMEA Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 269 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 270 LAMEA Retail Pharmacy Market by Country, 2023 - 2029, USD Million
  • TABLE 271 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 272 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 273 LAMEA Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 274 LAMEA Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 275 Brazil Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 276 Brazil Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 277 Brazil Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 278 Brazil Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 279 Brazil Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 280 Brazil Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 281 Brazil Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 282 Brazil Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 283 Argentina Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 284 Argentina Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 285 Argentina Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 286 Argentina Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 287 Argentina Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 288 Argentina Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 289 Argentina Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 290 Argentina Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 291 UAE Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 292 UAE Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 293 UAE Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 294 UAE Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 295 UAE Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 296 UAE Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 297 UAE Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 298 UAE Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 299 Saudi Arabia Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 300 Saudi Arabia Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 301 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 302 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 303 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 304 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 305 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 306 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 307 South Africa Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 308 South Africa Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 309 South Africa Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 310 South Africa Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 311 South Africa Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 312 South Africa Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 313 South Africa Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 314 South Africa Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 315 Nigeria Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 316 Nigeria Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 317 Nigeria Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 318 Nigeria Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 319 Nigeria Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 320 Nigeria Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 321 Nigeria Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 322 Nigeria Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 323 Rest of LAMEA Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
  • TABLE 324 Rest of LAMEA Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
  • TABLE 325 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 326 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 327 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 328 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 329 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 330 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 331 Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 332 Key Information - Ipsen Pharma Biotech SAS
  • TABLE 333 Key information - Merz Pharma GmbH & Co. KGaA
  • TABLE 334 Key information - Mallinckrodt PLC
  • TABLE 335 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 336 Key Information - Eisai Co., Ltd.
  • TABLE 337 Key Information - Endo International PLC
  • TABLE 338 Key Information - Vertical Pharmaceuticals, LLC
  • TABLE 339 Key Information - SteriMax Inc.
  • TABLE 340 Key Information - Metacel Pharmaceuticals, LLC.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Muscle Relaxant Drugs Market Share by Drug Type, 2022
  • FIG 3 Global Muscle Relaxant Drugs Market Share by Drug Type, 2029
  • FIG 4 Global Muscle Relaxant Drugs Market by Drug Type, 2019 - 2029, USD Million
  • FIG 5 Global Muscle Relaxant Drugs Market Share by Route of Administration, 2022
  • FIG 6 Global Muscle Relaxant Drugs Market Share by Route of Administration, 2029
  • FIG 7 Global Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2029, USD Million
  • FIG 8 Global Muscle Relaxant Drugs Market Share by Distribution Channel, 2022
  • FIG 9 Global Muscle Relaxant Drugs Market Share by Distribution Channel, 2029
  • FIG 10 Global Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2029, USD Million
  • FIG 11 Global Muscle Relaxant Drugs Market Share by Region, 2022
  • FIG 12 Global Muscle Relaxant Drugs Market Share by Region, 2029
  • FIG 13 Global Muscle Relaxant Drugs Market by Region, 2019 - 2029, USD Million
目次

The Global Muscle Relaxant Drugs Market size is expected to reach $4.7 billion by 2029, rising at a market growth of 4.3% CAGR during the forecast period.

Neuromuscular Blocking Agents are significantly capturing the market because of the increasing prevalence of skin diseases and damaging effects of ultraviolet radiation, the rising disposable income leading to increased expenditures on facial aesthetics therapy, and the rising use of neuromuscular blocking agents in surgical procedures. Thus, Neuromuscular Blocking Agents is expected to generate more than 37% share by 2029. More than 882 million individuals in 44 countries remain at risk for lymphatic filariasis in 2021, and preventative treatment is needed to halt the development of this parasitic ailment. 51 million individuals were sick as of 2018-a 74% decrease since the Global Programme to Eliminate Lymphatic Filariasis of the WHO began in 2000. Some of the factors impacting the market are the increase in Musculoskeletal Conditions, the increasing number of senior citizens, and adverse muscle relaxant side effects.

The most prevalent type of non-cancer pain is discomfort felt in musculoskeletal structures. According to the WHO, 1.71 billion people globally have musculoskeletal disorders, including rheumatoid arthritis, osteoarthritis, amputation, low back pain, neck discomfort, fractures, and other injuries. According to WHO, by 2030, one in six people will be 60 or elderly. There will be 1.4 billion individuals over 60, up from 1 billion in 2020. By 2050, the global population of individuals aged 60 and elderly will have doubled to 2.1 billion. In addition, the number of individuals aged 80 or older is projected to triple between 2020 and 2050, reaching 426 million. Due to the high need for demyelinating disease treatments among this population, the market has considerable growth potential.

However, patients with a history of liver disease, seizures, and other medical conditions or issues are at an increased risk for adverse effects. In addition, pregnant women who intend to become pregnant or are breastfeeding require special attention. As total body relaxants, muscle relaxants typically induce drowsiness or grogginess. As a result, it is unsafe to operate a vehicle or make vital decisions while under the influence of muscle relaxants.

Drug Type Outlook

Based on drug type, the market is segmented into skeletal, facial muscle relaxant drugs and neuromuscular blocking agents. The skeletal segment dominated the market with maximum revenue share in 2022. This is because skeletal muscle relaxants were initially approved to treat muscle spasms and back pain temporarily. Now, they are commonly used to treat chronic pain as well as a variety of other conditions. In addition, people seek medical assistance for a variety of reasons, but the most common one is pain. Thus, their use for the treatment of chronic pain and muscle spasms is expected to propel the segment's growth.

Route of Administration Outlook

On the basis of route of administration, the market is divided into oral and injectable. The injectable segment procured a substantial revenue share in the market in 2022. This is due to the fact that the most important companies in the market are working on the creation of innovative new items. Before undergoing general anesthesia, this muscle relaxant is given to the patient. Also, one of the most well-known applications of muscle relaxant injections in anti-aging medication is to reduce the appearance of wrinkles and lines on the forehead and the eyelids, which aids in the segment's growth.

Distribution Channel Outlook

By distribution channel, the market is classified into hospital pharmacy, retail pharmacy and online pharmacy. The hospital pharmacy segment witnessed the largest revenue share in the market in 2022. This is owing to the expanding awareness and an increase in clinical and hospital visits. In addition, the increasing geriatric population is a significant factor propelling the segment's expansion. This is due to the fact that the elderly are frequently hospitalized for a variety of chronic disorders for which they receive such medications. Thus, the segment is expected to propel due to the growing hospital admissions and the rising geriatric population.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the market in 2022. The growth is attributed to increased government investment, a rise in the incidence of chronic diseases, and the region's high-quality infrastructure. Due to the increasing number of surgical procedures and high disposable income, the market is expected to grow. Also, the presence of a large elderly population in this region contributes to the high prevalence of chronic back pain and further surge the market growth in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amneal Pharmaceuticals, Inc., Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Mallinckrodt PLC, Teva Pharmaceuticals Industries Ltd., Eisai Co., Ltd., Endo International PLC, Vertical Pharmaceuticals, LLC, SteriMax Inc., and Metacel Pharmaceuticals, LLC.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

  • Skeletal
  • Neuromuscular Blocking Agents
  • Facial Muscle Relaxant Drugs

By Route of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Amneal Pharmaceuticals, Inc.
  • Ipsen Pharma Biotech SAS
  • Merz Pharma GmbH & Co. KGaA
  • Mallinckrodt PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Eisai Co., Ltd.
  • Endo International PLC
  • Vertical Pharmaceuticals, LLC
  • SteriMax Inc.
  • Metacel Pharmaceuticals, LLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Muscle Relaxant Drugs Market, by Drug Type
    • 1.4.2 Global Muscle Relaxant Drugs Market, by Route of Administration
    • 1.4.3 Global Muscle Relaxant Drugs Market, by Distribution Channel
    • 1.4.4 Global Muscle Relaxant Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Muscle Relaxant Drugs Market by Drug Type

  • 3.1 Global Skeletal Market by Region
  • 3.2 Global Neuromuscular Blocking Agents Market by Region
  • 3.3 Global Facial Muscle Relaxant Drugs Market by Region

Chapter 4. Global Muscle Relaxant Drugs Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Injectable Market by Region

Chapter 5. Global Muscle Relaxant Drugs Market by Distribution Channel

  • 5.1 Global Hospital Pharmacy Market by Region
  • 5.2 Global Retail Pharmacy Market by Region
  • 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Muscle Relaxant Drugs Market by Region

  • 6.1 North America Muscle Relaxant Drugs Market
    • 6.1.1 North America Muscle Relaxant Drugs Market by Drug Type
      • 6.1.1.1 North America Skeletal Market by Country
      • 6.1.1.2 North America Neuromuscular Blocking Agents Market by Country
      • 6.1.1.3 North America Facial Muscle Relaxant Drugs Market by Country
    • 6.1.2 North America Muscle Relaxant Drugs Market by Route of Administration
      • 6.1.2.1 North America Oral Market by Country
      • 6.1.2.2 North America Injectable Market by Country
    • 6.1.3 North America Muscle Relaxant Drugs Market by Distribution Channel
      • 6.1.3.1 North America Hospital Pharmacy Market by Country
      • 6.1.3.2 North America Retail Pharmacy Market by Country
      • 6.1.3.3 North America Online Pharmacies Market by Country
    • 6.1.4 North America Muscle Relaxant Drugs Market by Country
      • 6.1.4.1 US Muscle Relaxant Drugs Market
        • 6.1.4.1.1 US Muscle Relaxant Drugs Market by Drug Type
        • 6.1.4.1.2 US Muscle Relaxant Drugs Market by Route of Administration
        • 6.1.4.1.3 US Muscle Relaxant Drugs Market by Distribution Channel
      • 6.1.4.2 Canada Muscle Relaxant Drugs Market
        • 6.1.4.2.1 Canada Muscle Relaxant Drugs Market by Drug Type
        • 6.1.4.2.2 Canada Muscle Relaxant Drugs Market by Route of Administration
        • 6.1.4.2.3 Canada Muscle Relaxant Drugs Market by Distribution Channel
      • 6.1.4.3 Mexico Muscle Relaxant Drugs Market
        • 6.1.4.3.1 Mexico Muscle Relaxant Drugs Market by Drug Type
        • 6.1.4.3.2 Mexico Muscle Relaxant Drugs Market by Route of Administration
        • 6.1.4.3.3 Mexico Muscle Relaxant Drugs Market by Distribution Channel
      • 6.1.4.4 Rest of North America Muscle Relaxant Drugs Market
        • 6.1.4.4.1 Rest of North America Muscle Relaxant Drugs Market by Drug Type
        • 6.1.4.4.2 Rest of North America Muscle Relaxant Drugs Market by Route of Administration
        • 6.1.4.4.3 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel
  • 6.2 Europe Muscle Relaxant Drugs Market
    • 6.2.1 Europe Muscle Relaxant Drugs Market by Drug Type
      • 6.2.1.1 Europe Skeletal Market by Country
      • 6.2.1.2 Europe Neuromuscular Blocking Agents Market by Country
      • 6.2.1.3 Europe Facial Muscle Relaxant Drugs Market by Country
    • 6.2.2 Europe Muscle Relaxant Drugs Market by Route of Administration
      • 6.2.2.1 Europe Oral Market by Country
      • 6.2.2.2 Europe Injectable Market by Country
    • 6.2.3 Europe Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.3.1 Europe Hospital Pharmacy Market by Country
      • 6.2.3.2 Europe Retail Pharmacy Market by Country
      • 6.2.3.3 Europe Online Pharmacies Market by Country
    • 6.2.4 Europe Muscle Relaxant Drugs Market by Country
      • 6.2.4.1 Germany Muscle Relaxant Drugs Market
        • 6.2.4.1.1 Germany Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.1.2 Germany Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.1.3 Germany Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.4.2 UK Muscle Relaxant Drugs Market
        • 6.2.4.2.1 UK Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.2.2 UK Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.2.3 UK Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.4.3 France Muscle Relaxant Drugs Market
        • 6.2.4.3.1 France Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.3.2 France Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.3.3 France Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.4.4 Russia Muscle Relaxant Drugs Market
        • 6.2.4.4.1 Russia Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.4.2 Russia Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.4.3 Russia Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.4.5 Spain Muscle Relaxant Drugs Market
        • 6.2.4.5.1 Spain Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.5.2 Spain Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.5.3 Spain Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.4.6 Italy Muscle Relaxant Drugs Market
        • 6.2.4.6.1 Italy Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.6.2 Italy Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.6.3 Italy Muscle Relaxant Drugs Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Muscle Relaxant Drugs Market
        • 6.2.4.7.1 Rest of Europe Muscle Relaxant Drugs Market by Drug Type
        • 6.2.4.7.2 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration
        • 6.2.4.7.3 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel
  • 6.3 Asia Pacific Muscle Relaxant Drugs Market
    • 6.3.1 Asia Pacific Muscle Relaxant Drugs Market by Drug Type
      • 6.3.1.1 Asia Pacific Skeletal Market by Country
      • 6.3.1.2 Asia Pacific Neuromuscular Blocking Agents Market by Country
      • 6.3.1.3 Asia Pacific Facial Muscle Relaxant Drugs Market by Country
    • 6.3.2 Asia Pacific Muscle Relaxant Drugs Market by Route of Administration
      • 6.3.2.1 Asia Pacific Oral Market by Country
      • 6.3.2.2 Asia Pacific Injectable Market by Country
    • 6.3.3 Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
      • 6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
      • 6.3.3.3 Asia Pacific Online Pharmacies Market by Country
    • 6.3.4 Asia Pacific Muscle Relaxant Drugs Market by Country
      • 6.3.4.1 China Muscle Relaxant Drugs Market
        • 6.3.4.1.1 China Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.1.2 China Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.1.3 China Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.4.2 Japan Muscle Relaxant Drugs Market
        • 6.3.4.2.1 Japan Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.2.2 Japan Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.2.3 Japan Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.4.3 India Muscle Relaxant Drugs Market
        • 6.3.4.3.1 India Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.3.2 India Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.3.3 India Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.4.4 South Korea Muscle Relaxant Drugs Market
        • 6.3.4.4.1 South Korea Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.4.2 South Korea Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.4.3 South Korea Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.4.5 Singapore Muscle Relaxant Drugs Market
        • 6.3.4.5.1 Singapore Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.5.2 Singapore Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.5.3 Singapore Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.4.6 Malaysia Muscle Relaxant Drugs Market
        • 6.3.4.6.1 Malaysia Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.6.2 Malaysia Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.6.3 Malaysia Muscle Relaxant Drugs Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Muscle Relaxant Drugs Market
        • 6.3.4.7.1 Rest of Asia Pacific Muscle Relaxant Drugs Market by Drug Type
        • 6.3.4.7.2 Rest of Asia Pacific Muscle Relaxant Drugs Market by Route of Administration
        • 6.3.4.7.3 Rest of Asia Pacific Muscle Relaxant Drugs Market by Distribution Channel
  • 6.4 LAMEA Muscle Relaxant Drugs Market
    • 6.4.1 LAMEA Muscle Relaxant Drugs Market by Drug Type
      • 6.4.1.1 LAMEA Skeletal Market by Country
      • 6.4.1.2 LAMEA Neuromuscular Blocking Agents Market by Country
      • 6.4.1.3 LAMEA Facial Muscle Relaxant Drugs Market by Country
    • 6.4.2 LAMEA Muscle Relaxant Drugs Market by Route of Administration
      • 6.4.2.1 LAMEA Oral Market by Country
      • 6.4.2.2 LAMEA Injectable Market by Country
    • 6.4.3 LAMEA Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.3.1 LAMEA Hospital Pharmacy Market by Country
      • 6.4.3.2 LAMEA Retail Pharmacy Market by Country
      • 6.4.3.3 LAMEA Online Pharmacies Market by Country
    • 6.4.4 LAMEA Muscle Relaxant Drugs Market by Country
      • 6.4.4.1 Brazil Muscle Relaxant Drugs Market
        • 6.4.4.1.1 Brazil Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.1.2 Brazil Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.1.3 Brazil Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.4.2 Argentina Muscle Relaxant Drugs Market
        • 6.4.4.2.1 Argentina Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.2.2 Argentina Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.2.3 Argentina Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.4.3 UAE Muscle Relaxant Drugs Market
        • 6.4.4.3.1 UAE Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.3.2 UAE Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.3.3 UAE Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Muscle Relaxant Drugs Market
        • 6.4.4.4.1 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.4.2 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.4.3 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.4.5 South Africa Muscle Relaxant Drugs Market
        • 6.4.4.5.1 South Africa Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.5.2 South Africa Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.5.3 South Africa Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.4.6 Nigeria Muscle Relaxant Drugs Market
        • 6.4.4.6.1 Nigeria Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.6.2 Nigeria Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.6.3 Nigeria Muscle Relaxant Drugs Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Muscle Relaxant Drugs Market
        • 6.4.4.7.1 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type
        • 6.4.4.7.2 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration
        • 6.4.4.7.3 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 Amneal Pharmaceuticals, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Acquisition and Mergers:
  • 7.2 Ipsen Pharma Biotech SAS
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Product Launches and Product Expansions:
  • 7.3 Merz Pharma GmbH & Co. KGaA
    • 7.3.1 Company Overview
  • 7.4 Mallinckrodt PLC
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 Teva Pharmaceutical Industries Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expenses
  • 7.6 Eisai Co., Ltd.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Endo International PLC
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Vertical Pharmaceuticals, LLC
    • 7.8.1 Company Overview
  • 7.9 SteriMax Inc.
    • 7.9.1 Company Overview
  • 7.10. Metacel Pharmaceuticals, LLC.
    • 7.10.1 Company Overview